Cargando…
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
This is a cross-sectional study of 29 published cases of acute myopericarditis following COVID-19 mRNA vaccination. The most common presentation was chest pain within 1–5 days after the second dose of mRNA COVID-19 vaccination. All patients had an elevated troponin. Cardiac magnetic resonance imagin...
Autores principales: | Das, Bibhuti B., Moskowitz, William B., Taylor, Mary B., Palmer, April |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305058/ https://www.ncbi.nlm.nih.gov/pubmed/34356586 http://dx.doi.org/10.3390/children8070607 |
Ejemplares similares
-
COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?
por: Das, Bibhuti B
Publicado: (2020) -
COVID-19 and Myocarditis: What Do We Know So Far?
por: Pirzada, Ashar, et al.
Publicado: (2020) -
Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021) -
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022) -
What we know so far
Publicado: (2021)